MaxCyte, Inc: MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and ...
MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery ...